Key result
Alternative stroke therapies in Asia show unproven benefit, requiring rigorous clinical trials for validation.
Answers are grounded in this paper and cite their sources.
Patients seek alternative therapies for stroke in Asia due to dissatisfaction with poststroke recovery. Most alternative therapies are of unproven benefit in rehabilitation. Well-conducted trials are needed to better define the role of alternative therapies in the process of poststroke recovery; the CHInese Medicine Neuroaid Efficacy on Stroke recovery is ongoing. However, further studies, better health education and rehabilitation services and centers are also required.
No takes yet. Share an insight, caveat, or question.
Pandian et al. (2011) conducted a review in Stroke. Alternative therapies was evaluated. Alternative therapies for stroke recovery in Asia remain of unproven benefit, highlighting the need for well-conducted clinical trials to define their efficacy.
Synapse has enriched 10 related papers. Consider them for comparative context: